Items

PHURI Researchers conduct the most comprehensive analysis to date linking plasma proteins to genetic variation in individuals with type 2 diabetes from continental Africa

By combining genomic and plasma proteomic data from a Ugandan cohort, the researchers mapped nearly 400 genetic regions that regulate circulating protein levels – 58 of them previously unknown in African-ancestry individuals.

Date added: Tuesday, January 20, 2026

Prof. Claudia Langenberg Awarded ERC Consolidator Grant

We are proud to celebrate a major milestone for Precision Healthcare and for Queen Mary University of London. This year, four Queen Mary academics have been awarded prestigious European Research Council (ERC) Consolidator Grants, placing them among just 349 researchers selected from more than 3,000 applicants across Europe.

Date added: Tuesday, December 9, 2025

Prof. Langenberg named in the top 7 Best Female Scientists in the UK

The latest Research.com rankings have named Professor Claudia Langenberg, PHURI, QMUL among the top 100 scientists in the UK, recognising her significant contribution to her field.

Date added: Monday, October 13, 2025

Decoding Immune Cell Dialogue to Predict Immunotherapy Responses

An interdisciplinary team, including scientists from PHURI, has developed a pioneering method to decode cellular communication. This innovation sheds new light on the hidden conversations between cells and opens the door to more effective cancer treatments. By applying this method, the researchers have shown how it can deepen our understanding of novel immunotherapies that harness the patient’s own immune system to combat cancer.

Date added: Tuesday, September 9, 2025

How immune cells communicate to fight disease and cancer 

An interdisciplinary team of scientists from the Berlin Institute of Health at Charité (BIH), the Max Delbrück Center, the German Cancer Research Center (DKFZ), the Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM) and Queen Mary University of London has developed a technology to decode immune cell communication.

Date added: Monday, August 11, 2025

Professor Claudia Langenberg elected as Fellow of the Academy of Medical Sciences

Professor Claudia Langenberg from PHURI and Queen Mary joins 54 exceptional biomedical and health scientists elected by the Academy to its prestigious Fellowship.

Date added: Thursday, May 22, 2025

Diabetes Is Rising in Africa. Could It Lead to New Breakthroughs?

Growing rates of type 2 diabetes across the African content offer scientists hope of creating new, more inclusive treatments.

Date added: Saturday, May 10, 2025

When blood cancer starts to spread

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response in the region changes, researchers from Berlin and Heidelberg report in “Science Immunology.” The detailed insights into cancer progression could advance diagnostics and treatment.

Date added: Wednesday, February 12, 2025

UK Biobank launches the world’s largest protein study to unlock new medical breakthroughs

Research led by Queen Mary’s Professor Claudia Langenberg and her team has helped to prove the effectiveness of large-scale protein studies using UK Biobank data to understand disease

Date added: Friday, January 10, 2025

Progressing Precision Healthcare

Professor Claudia Langenberg, Director of the Precision Healthcare University Research Institute (PHURI) at Queen Mary University of London, discusses the future of precision medicine. With an impressive background as Professor of Computational Medicine at the Berlin Institute of Health at Charité Universitätsmedizin, Germany, and former Programme Leader at the MRC Epidemiology Unit at the University of Cambridge, Professor Langenberg brings invaluable insight into the cutting-edge developments shaping this rapidly evolving field. In this interview, we explore the most significant trends in precision medicine, the challenges of deploying these approaches at scale, and the role of data-driven techniques and artificial intelligence. Professor Langenberg shares her views on the UK’s position as a global leader in precision medicine, highlighting the unique opportunities presented by North-East London, including the Barts Health Data Platform

Date added: Tuesday, November 12, 2024

Blood proteins predict the risk of developing more than 60 diseases

Protein ‘signatures’, which can be obtained via a blood sample, can be used to predict the onset of 67 diseases including multiple myeloma, non-Hodgkin lymphoma, motor neurone disease, pulmonary fibrosis, and dilated cardiomyopathy. Using protein information to predict the onset of diseases could help with timely diagnosis, early initiation of treatment and improved patient outcomes.

Date added: Monday, July 22, 2024

Reporting guidelines for precision medicine research of clinical relevance: the BePRECISE checklist

The inaugural reporting guidelines for precision medicine research have been published in Nature Medicine

Date added: Friday, July 19, 2024

Complex patterns of multimorbidity associated with severe COVID-19 and long COVID

Early evidence that patients with (multiple) pre-existing diseases are at highest risk for severe COVID-19 has been instrumental in the pandemic to allocate critical care resources and later vaccination schemes. However, systematic studies exploring the breadth of medical diagnoses are scarce but may help to understand severe COVID-19 among patients at supposedly low risk.

Date added: Monday, July 8, 2024

Global main menu

Study at Queen Mary

Experience Queen Mary

Subjects

Research and Innovation

Research by faculties and centres

Collaborations and partnerships